MX2022003962A - Blood glucose control system. - Google Patents
Blood glucose control system.Info
- Publication number
- MX2022003962A MX2022003962A MX2022003962A MX2022003962A MX2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A MX 2022003962 A MX2022003962 A MX 2022003962A
- Authority
- MX
- Mexico
- Prior art keywords
- therapy
- value
- blood glucose
- control
- control parameter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/40—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F8/00—Arrangements for software engineering
- G06F8/60—Software deployment
- G06F8/65—Updates
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F8/00—Arrangements for software engineering
- G06F8/60—Software deployment
- G06F8/65—Updates
- G06F8/656—Updates while running
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M2005/1401—Functional features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/07—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/18—General characteristics of the apparatus with alarm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3303—Using a biosensor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3546—Range
- A61M2205/3569—Range sublocal, e.g. between console and disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/609—Biometric patient identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1407—Infusion of two or more substances
- A61M5/1408—Infusion of two or more substances in parallel, e.g. manifolds, sequencing valves
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Theoretical Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Software Systems (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Computer Security & Cryptography (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- External Artificial Organs (AREA)
Abstract
A blood glucose control system is configured to modify therapy provide to a subject and determine whether the modified therapy results in a statistically significant improvement in glycemic control. The system obtains glycemic control information resulting from delivery of first therapy using a first value of a control parameter and determines a first effect corresponding to the first therapy. The control parameter is set to a second value that differs from the first value. The system obtains glycemic control information resulting from the delivery of the second therapy using the second value of the control parameter and determines a second effect corresponding to the second therapy. The system can perform a comparative assessment and determine whether the second value for the control parameter results in a statistically significant improvement in glycemic control for the subject.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962910970P | 2019-10-04 | 2019-10-04 | |
US201962911017P | 2019-10-04 | 2019-10-04 | |
US201962911143P | 2019-10-04 | 2019-10-04 | |
US202062987842P | 2020-03-10 | 2020-03-10 | |
US202063037472P | 2020-06-10 | 2020-06-10 | |
PCT/US2020/042198 WO2021011699A1 (en) | 2019-07-16 | 2020-07-15 | Ambulatory device and components thereof |
PCT/US2020/042195 WO2021011697A1 (en) | 2019-07-16 | 2020-07-15 | Blood glucose control system |
PCT/US2020/042269 WO2021011738A1 (en) | 2019-07-16 | 2020-07-16 | Blood glucose control system |
PCT/US2020/054130 WO2021067856A1 (en) | 2019-10-04 | 2020-10-02 | Blood glucose control system |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022003962A true MX2022003962A (en) | 2022-07-21 |
Family
ID=75336591
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022003962A MX2022003962A (en) | 2019-10-04 | 2020-10-02 | Blood glucose control system. |
MX2022003961A MX2022003961A (en) | 2019-10-04 | 2020-10-02 | Blood glucose control system. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022003961A MX2022003961A (en) | 2019-10-04 | 2020-10-02 | Blood glucose control system. |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP4042436A4 (en) |
JP (2) | JP2022551265A (en) |
CN (2) | CN114902344A (en) |
AU (2) | AU2020358856A1 (en) |
CA (2) | CA3151777A1 (en) |
DE (2) | DE112020004780T5 (en) |
IL (2) | IL291671A (en) |
MX (2) | MX2022003962A (en) |
WO (2) | WO2021067856A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210060244A1 (en) * | 2019-08-28 | 2021-03-04 | Medtronic Minimed, Inc. | Method and system for verifying whether a non-medical client device is operating correctly with a medical device controlled by the non-medical client device and causing a notification to be generated |
US20220148724A1 (en) * | 2020-11-11 | 2022-05-12 | Itamar Medical Ltd. | Sleep apnea test device |
WO2022204705A1 (en) * | 2021-03-25 | 2022-09-29 | Beta Bionics, Inc. | Emergency medicament dose control |
FR3133478A1 (en) * | 2022-03-11 | 2023-09-15 | Diabeloop | Computerized system for communicating treatment information to a user |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7591801B2 (en) * | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
EP1881786B1 (en) | 2005-05-13 | 2017-11-15 | Trustees of Boston University | Fully automated control system for type 1 diabetes |
EP2171630A1 (en) * | 2007-06-27 | 2010-04-07 | F. Hoffmann-Roche AG | System and method for developing patient specific therapies based on modeling of patient physiology |
US10231077B2 (en) * | 2007-07-03 | 2019-03-12 | Eingot Llc | Records access and management |
DK2393414T3 (en) * | 2009-02-04 | 2016-01-18 | Sanofi Aventis Deutschland | MEDICAL SYSTEM AND A method for providing glycemic control glycemic response BASED ON INFORMATION |
EP3173014B1 (en) * | 2009-07-23 | 2021-08-18 | Abbott Diabetes Care, Inc. | Real time management of data relating to physiological control of glucose levels |
US8726266B2 (en) * | 2010-05-24 | 2014-05-13 | Abbott Diabetes Care Inc. | Method and system for updating a medical device |
EP2633456B1 (en) | 2010-10-31 | 2019-09-04 | Trustees of Boston University | Blood glucose control system |
US8745298B2 (en) * | 2011-10-24 | 2014-06-03 | Roche Diagnostics Operations, Inc. | Interoperability enhancement that supports connectivity of applications on a medical device |
SG10201705568YA (en) * | 2012-12-21 | 2017-08-30 | Deka Products Lp | System and apparatus for electronic patient care using web services |
US9242043B2 (en) * | 2013-03-15 | 2016-01-26 | Tandem Diabetes Care, Inc. | Field update of an ambulatory infusion pump system |
EP2851823A1 (en) * | 2013-09-20 | 2015-03-25 | Sanofi-Aventis Deutschland GmbH | Data management unit for supporting health control |
US10105488B2 (en) * | 2013-12-12 | 2018-10-23 | Medtronic Minimed, Inc. | Predictive infusion device operations and related methods and systems |
US9486580B2 (en) * | 2014-01-31 | 2016-11-08 | Aseko, Inc. | Insulin management |
CN106456064B (en) | 2014-01-31 | 2020-11-27 | 波士顿大学董事会 | Offline glucose control based on previous epochs |
EP3148419A4 (en) * | 2014-05-27 | 2018-01-24 | ResMed Limited | Remote respiratory therapy device management |
WO2016019133A1 (en) * | 2014-07-30 | 2016-02-04 | Tandem Diabetes Care, Inc. | Temporary suspension for closed-loop medicament therapy |
WO2016138240A1 (en) * | 2015-02-27 | 2016-09-01 | Zoll Medical Corporation | Downloading and booting method and system for a wearable medical device |
MX2017012128A (en) * | 2015-03-24 | 2018-02-09 | Ares Trading Sa | Patient care system. |
JP2018525093A (en) | 2015-08-07 | 2018-09-06 | トラスティーズ オブ ボストン ユニバーシティ | Glucose control system with automatic adaptation of glucose targets |
US9886556B2 (en) * | 2015-08-20 | 2018-02-06 | Aseko, Inc. | Diabetes management therapy advisor |
US10987468B2 (en) * | 2016-01-05 | 2021-04-27 | Bigfoot Biomedical, Inc. | Operating multi-modal medicine delivery systems |
CA3009351A1 (en) * | 2016-01-14 | 2017-07-20 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
US20170259072A1 (en) * | 2016-03-14 | 2017-09-14 | Qualcomm Incorporated | System architecture for medical implant |
US10426342B2 (en) * | 2016-03-31 | 2019-10-01 | Zoll Medical Corporation | Remote access for ambulatory medical device |
US10937536B2 (en) * | 2016-07-15 | 2021-03-02 | Universität Bern | Estimation of insulin based on reinforcement learning |
US10896245B2 (en) * | 2016-08-29 | 2021-01-19 | Bigfoot Biomedical, Inc. | Network topology for insulin pump systems |
WO2019089324A1 (en) * | 2017-10-30 | 2019-05-09 | Dexcom, Inc. | Diabetes management partner interface for wireless communication of analyte data |
CA3085930A1 (en) * | 2017-12-21 | 2019-06-27 | Eli Lilly And Company | Closed loop control of physiological glucose |
EP3603401B1 (en) | 2018-08-02 | 2021-12-08 | Radie B.V. | Device and method for portioning a dough mass |
EP3998943A4 (en) * | 2019-07-16 | 2023-09-06 | Beta Bionics, Inc. | Blood glucose control system |
-
2020
- 2020-10-02 DE DE112020004780.6T patent/DE112020004780T5/en active Pending
- 2020-10-02 CN CN202080084498.8A patent/CN114902344A/en active Pending
- 2020-10-02 MX MX2022003962A patent/MX2022003962A/en unknown
- 2020-10-02 EP EP20872651.3A patent/EP4042436A4/en active Pending
- 2020-10-02 WO PCT/US2020/054130 patent/WO2021067856A1/en active Search and Examination
- 2020-10-02 WO PCT/US2020/054025 patent/WO2021067767A1/en active Search and Examination
- 2020-10-02 AU AU2020358856A patent/AU2020358856A1/en active Pending
- 2020-10-02 AU AU2020356952A patent/AU2020356952A1/en active Pending
- 2020-10-02 DE DE112020004762.8T patent/DE112020004762T5/en active Pending
- 2020-10-02 CA CA3151777A patent/CA3151777A1/en active Pending
- 2020-10-02 CA CA3151782A patent/CA3151782A1/en active Pending
- 2020-10-02 EP EP20872387.4A patent/EP4042441A4/en active Pending
- 2020-10-02 JP JP2022520425A patent/JP2022551265A/en active Pending
- 2020-10-02 JP JP2022520424A patent/JP2023503792A/en active Pending
- 2020-10-02 MX MX2022003961A patent/MX2022003961A/en unknown
- 2020-10-02 CN CN202080084028.1A patent/CN114868200A/en active Pending
-
2022
- 2022-03-24 IL IL291671A patent/IL291671A/en unknown
- 2022-03-28 IL IL291746A patent/IL291746A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP4042436A1 (en) | 2022-08-17 |
CN114902344A (en) | 2022-08-12 |
MX2022003961A (en) | 2022-07-21 |
IL291746A (en) | 2022-05-01 |
CN114868200A (en) | 2022-08-05 |
WO2021067767A1 (en) | 2021-04-08 |
JP2023503792A (en) | 2023-02-01 |
DE112020004780T5 (en) | 2022-09-01 |
JP2022551265A (en) | 2022-12-08 |
EP4042436A4 (en) | 2023-10-04 |
CA3151782A1 (en) | 2021-04-08 |
EP4042441A4 (en) | 2023-10-11 |
AU2020356952A1 (en) | 2022-04-14 |
AU2020358856A1 (en) | 2022-04-14 |
WO2021067856A1 (en) | 2021-04-08 |
IL291671A (en) | 2022-05-01 |
EP4042441A1 (en) | 2022-08-17 |
CA3151777A1 (en) | 2021-04-08 |
DE112020004762T5 (en) | 2022-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022003962A (en) | Blood glucose control system. | |
MX2022000670A (en) | Blood glucose control system. | |
AU2017363960A8 (en) | Methods and systems for managing patient compliance | |
MX2022001442A (en) | Systems, devices, and methods relating to medication dose guidance. | |
MX2018007840A (en) | Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration. | |
EP3773880A4 (en) | Therapeutic modulation to treat blood glucose abnormalities, including type 2 diabetes, and/or reduce hba1c levels, and associated systems and methods | |
EP4252833A3 (en) | Microstimulation sleep disordered breathing (sdb) therapy device | |
PH12017501818A1 (en) | Fgfr/pd-1 combination therapy for the treatment of cancer | |
MX2019014832A (en) | Respiratory volume monitor and ventilator. | |
EP4299106A3 (en) | Accessing spinal network to enable respiratory function | |
SG10201902151UA (en) | Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data | |
MX2021007816A (en) | Systems and methods for intelligent gas source management and/or systems and methods for delivery of therapeutic gas and/or enhanced performance verification for therapeutic gas delivery. | |
WO2018111997A3 (en) | System and method for enhancing learning with neural modulation | |
MX2018014279A (en) | Therapeutic treatment of breast cancer based on c-maf status. | |
MX2020006034A (en) | Computer-implemented method and system for producing orthopedic care. | |
MX2020000190A (en) | Methods of treating heart failure with cardiac sarcomere activators. | |
WO2017019455A3 (en) | Systems and methods for phototherapy control | |
AU2018271862A1 (en) | Combination therapy | |
WO2018185555A3 (en) | Systems, apparatuses, kits and methods for improved medical procedures | |
WO2020161722A8 (en) | Smart dynamic mattress for prevention and treatment of pressure wounds | |
중식엄 | Operating the hospitalist system | |
MX2021005568A (en) | Medical device usage monitoring system and method. | |
WO2020109233A3 (en) | Trmt2a inhibitors for use in the treatment of polyglutamine diseases | |
WO2019055776A3 (en) | Compositions and methods for treatment of diseases involving cxcl1 function | |
WO2021239928A3 (en) | Treatment of cardiometabolic disease with inhibitors of type i interferon signalling |